Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/14244

Title: Amphipathic polymer-mediated uptake of trehalose for dimethyl sulfoxide-free human cell cryopreservation
Authors: Sharp, Duncan M.C.
Picken, Andrew
Morris, Timothy J.
Hewitt, Christopher J.
Coopman, Karen
Slater, Nigel K.H.
Keywords: Cryopreservation
Issue Date: 2013
Publisher: © The Authors. Published by Elsevier Inc.
Citation: SHARP, D.M.C. ... et al., 2013. Amphipathic polymer-mediated uptake of trehalose for dimethyl sulfoxide-free human cell cryopreservation. Cryobiology, 67 (3), pp. 305 - 311.
Abstract: For stem cell therapy to become a routine reality, one of the major challenges to overcome is their storage and transportation. Currently this is achieved by cryopreserving cells utilising the cryoprotectant dimethyl sulfoxide (MeSO). MeSO is toxic to cells, leads to loss of cell functionality, and can produce severe side effects in patients. Potentially, cells could be frozen using the cryoprotectant trehalose if it could be delivered into the cells at a sufficient concentration. The novel amphipathic membrane permeabilising agent PP-50 has previously been shown to enhance trehalose uptake by erythrocytes, resulting in increased cryosurvival. Here, this work was extended to the nucleated human cell line SAOS-2. Using the optimum PP-50 concentration and media osmolarity, cell viability post-thaw was 60±2%. In addition, the number of metabolically active cells 24h post-thaw, normalised to that before freezing, was found to be between 103±4% and 91±5%. This was found to be comparable to cells frozen using MeSO. Although reduced (by 22±2%, p=0.09), the doubling time was found not to be statistically different to the non-frozen control. This was in contrast to cells frozen using MeSO, where the doubling time was significantly reduced (by 41±4%, p=0.004). PP-50 mediated trehalose delivery into cells could represent an alternative cryopreservation protocol, suitable for research and therapeutic applications. © 2013 The Authors.
Description: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Full details of the CC BY licence are available at: http://creativecommons.org/licenses/by/3.0/
Sponsor: This work was supported by the Bioprocessing Research Industry Club (BRIC) – BBSRC grant number BB/I016961/1. The open access licence was funded by Open Access, University of Cambridge.
Version: Published
DOI: 10.1016/j.cryobiol.2013.09.002
URI: https://dspace.lboro.ac.uk/2134/14244
Publisher Link: http://dx.doi.org/10.1016/j.cryobiol.2013.09.002
ISSN: 0011-2240
Appears in Collections:Published Articles (Chemical Engineering)

Files associated with this item:

File Description SizeFormat
1-s2.0-S0011224013002216-main.pdfPublished version917.51 kBAdobe PDFView/Open


SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.